3.发表论文(具有代表性的5篇)
(1) Yelin Tang#, Weiting Pan#, Wenting Ding#, Xingye Pan, Junyi Zhu, Huiwen Chen, Xiaona Zhu, Jingyi Chen, Zijun Cheng, Yali Zhang*, Bing Zhang*. Prostaglandin E2 alleviates inflammatory response and lung injury through EP4/cAMP/IKK/NF-κB pathway. BBA - Molecular Basis of Disease, 2025, 1871(1) 167801. (2) Xiangting Ge#, Tingting Xu#, Meiyan Wang#, Lijiao Gao, Yue Tang, Ningjie Zhang, Rui Zheng, Weimin Zeng, Gaozhi Chen, Bing Zhang*, Yuanrong Dai*, Yali Zhang*. Chalcone-derivative L6H21 attenuates the OVA-induced asthma by targeting MD2. European Journal of Medical Research, 2024, 29(1):0949-2321. (3) Yali Zhang#,*, Wenxin Zhang#, Jueqian Yan#, Yelin Tang, Wenjing Jia, Zhengwei Xu, Mingjiang Xu, Nipon Chattipakorn, Yi Wang, Jianpeng Feng, Zhiguo Liu*, Guang Liang*. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2. Acta Pharmacologica Sinica, 2022, 43(1):76-85. (4) Yali Zhang#, Zhiguo Liu#, Jianzhang Wu, Bin Bai, Hongjin Chen, Zhongxiang Xiao, Lingfeng Chen, Yunjie Zhao, Hazel Lum, Yi Wang, Hong Zhang*, Guang Liang*. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity. European Journal of Medicinal Chemistry, 2018, 148: 291-305. (5) Yali Zhang#, Tingting Xu#, Zheer Pan#, Xiangting Ge, Chuchu Sun, Chun Lu, Hongjin Chen, Zhongxiang Xiao, Bing Zhang*, Yuanrong Dai*, Guang Liang*. Shikonin inhibits myeloid differentiation protein 2 to prevent LPS‐induced acute lung injury. British Journal of Pharmacology, 2018, 175(5): 840-854.
|